首页> 外国专利> NOVEL ACYLGUANIDINE DERIVATIVES AS INHIBITORS OF BONE RESORPTION AND AS VITRONECTIN RECEPTOR ANTAGONISTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

NOVEL ACYLGUANIDINE DERIVATIVES AS INHIBITORS OF BONE RESORPTION AND AS VITRONECTIN RECEPTOR ANTAGONISTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

机译:新的乙酰铝胍衍生物作为骨吸收抑制剂和维连蛋白受体拮抗剂,其制备方法和包含它们的药物组合物

摘要

The present invention relates to acylguanidine derivatives of the formula I CHEM in which R1, R2, R4, R5, R6, A, m and n have the meanings indicated in the patent claims, their physiologically tolerable salts and their prodrugs. The compounds of the formula I are valuable pharmaceutical active ingredients. They are vitronectin receptor antagonists and inhibitors of bone resorption by osteoclasts and are suitable, for example, for the therapy or prophylaxis of diseases which are caused at least partially by an undesired extent of bone resorption, for example of osteoporosis. The invention furthermore relates to processes for the preparation of compounds of the formula I, their use, in particular as pharmaceutical active ingredients, and pharmaceutical preparations comprising them.
机译:本发明涉及式I 的酰基胍衍生物,其中R 1,R 2,R 4,R 5,R 6,A,m和n具有所示的含义在专利权利要求中,它们的生理上可耐受的盐和它们的前药。式I化合物是有价值的药物活性成分。它们是玻连蛋白受体拮抗剂和破骨细胞的骨吸收抑制剂,并且适合例如用于治疗或预防至少部分地由不期望的骨吸收程度引起的疾病,例如骨质疏松症。本发明还涉及式I化合物的制备方法,其用途,特别是作为药物活性成分的用途,以及包含它们的药物制剂。

著录项

  • 公开/公告号HU0104912A3

    专利类型

  • 公开/公告日2002-09-30

    原文格式PDF

  • 申请/专利权人 AVENTIS PHARMA DEUTSCHLAND GMBH FRANKFURT/MAIN;

    申请/专利号HU20010004912

  • 发明设计人

    申请日1998-12-10

  • 分类号C07D239/16;

  • 国家 HU

  • 入库时间 2022-08-22 00:45:12

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号